HNGE — HINGE HEALTH INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying HNGE?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their HNGE position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime).
- +4 tracked investors reported holding HNGE at their latest filing
- +Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource
- −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.
About HINGE HEALTH INC (HNGE)
HINGE HEALTH INC (HNGE) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Philippe Laffont (Coatue Management), valued at $243M. Across recent filings, tracked investors recorded 6 new positions, 3 increased, 3 reduced, and 5 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in HNGE
How many top investors track HNGE
A small number of top investors own this.
HNGE Ownership Composition
How HINGE HEALTH INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant99.8%
- Macro0.2%
Tracked investors currently reporting HNGE
3 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares1.1MValue$89.7M% Portfolio0.01%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares195.7KValue$16.2M% Portfolio0.01%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares338.2KValue$28.1M% Portfolio0.03%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares3.6KValue$298.8K% Portfolio0.00%
Previously held HNGE
These investors reported HNGE in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Philippe Laffont | Coatue Management | 4.7M | $230.8M | Sep 30, 2025 |
| Chase Coleman | Tiger Global Management | 1.8M | $83.9M | Dec 31, 2025 |
| George Soros | Soros Fund Management | 78.6K | $3.9M | Sep 30, 2025 |
Recent activity
- $28.6MAug 14, 2025
- Unchanged$27.1M(0.00%)Nov 14, 2025
- Increased$83.9M(227.12%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- New$3.9MAug 14, 2025
- Increased$3.9M(4.75%)Nov 14, 2025
- Sold$0(-100.00%)Feb 13, 2026
- New$28.4MAug 14, 2025
- Reduced$21.9M(-18.73%)Nov 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- New$13.4MMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- $243.3MAug 14, 2025
- Unchanged$230.8M(0.00%)Nov 14, 2025
- Sold$0(-100.00%)May 15, 2026
- $15.5MAug 14, 2025
- Increased$18.5M(25.92%)Dec 9, 2025
- Reduced$254.5K(-98.73%)May 15, 2026
- Reduced$298.8K(-45.45%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold HNGE?
- 4 tracked institutional investors disclosed a position in HNGE (HINGE HEALTH INC) in their most recent 13F filing.
- Who is the largest institutional holder of HNGE?
- Philippe Laffont, Coatue Management, holds the largest disclosed position in HNGE, valued at $243M.
- Did institutional ownership of HNGE increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 3 increased, 3 reduced, and 5 fully exited HNGE.
- Where does this HNGE ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.